MRI microscopy of mouse and human pancreas with respective histology, demonstrating the ability of DTI maps (Fractional anisotropy and Axial diffusivity) to identify pre-malignant lesions (black ...
Performance of a blood-biomarker test for early detection of pancreatic ductal adenocarcinoma (PDAC) across all stages of disease versus a mixed control population. This is an ASCO Meeting Abstract ...
Surufatinib combined with TAS-102 in third- or later-line therapy of patients with metastatic pancreatic cancer (mPDAC): An open-label, single-arm, phase II study.
Pancreatic cancer remains one of the most challenging cancers to detect early, contributing to its reputation as a silent disease with poor survival rates. The pancreas—a leaf-shaped organ tucked ...
Pancreatic cancer (PC) presents substantial diagnostic challenges due to its aggressive nature and lack of early symptoms, leading to late detection and poor prognosis. According to recent cancer ...
Currently, no consensus exists regarding the definition of oligometastatic pancreatic ductal adenocarcinoma, its necessary diagnostic measures, and potential treatment approaches. To address these ...
Health on MSN
What's the difference between a CT scan and MRI?
Medically reviewed by Rony Kampalath, MD CT scans and MRIs are imaging procedures that help healthcare providers see inside your body.CT scans are generally faster, less expensive, and more widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results